Citations (100)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Anna Emilia Kern, Gregor Ortmayr, Alice Assinger & Patrick Starlinger. (2023) The role of microRNAs in the different phases of liver regeneration. Expert Review of Gastroenterology & Hepatology 17:10, pages 959-973.
Read now
Read now
Alexei J. Stuckel, Tripti Khare, Marc Bissonnette & Sharad Khare. (2022) Aberrant regulation of CXCR4 in cancer via deviant microRNA-targeted interactions. Epigenetics 17:13, pages 2318-2331.
Read now
Read now
Tomasz Kasela, Maciej Dąbala, Magdalena Mistarz, Weronika Wieczorek, Magdalena Wierzbik-Strońska, Kacper Boroń, Barbara Zawidlak-Węgrzyńska & Beniamin Oskar Grabarek. (2022) Effects of Cyclosporine A and Adalimumab on the expression profiles histaminergic system-associated genes and microRNAs regulating these genes in HaCaT cells. Cell Cycle 21:23, pages 2499-2516.
Read now
Read now
Xiaorong Jian, Dehua Yang, Li Wang & Hongxiang Wang. (2021) Downregulation of microRNA-200c-3p alleviates the aggravation of venous thromboembolism by targeting serpin family C member 1. Bioengineered 12:2, pages 11154-11166.
Read now
Read now
Articles from other publishers (96)
Emiliya Nikolova, Lili Laleva, Milko Milev, Toma Spiriev, Stoycho Stoyanov, Dilyan Ferdinandov, Vanyo Mitev & Albena Todorova. (2024) miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets. Non-coding RNA Research 9:1, pages 141-152.
Crossref
Crossref
Jiawei Wang, Feng Tian, Lili Cao, Ruochen Du, Jiahui Tong, Xueting Ding, Yitong Yuan & Chunfang Wang. (2023) Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review. Heliyon 9:12, pages e22914.
Crossref
Crossref
Ganna Aleshcheva, Christian Baumeier, Dominik Harms, C.‐Thomas Bock, Felicitas Escher & Heinz‐Peter Schultheiss. (2023) MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy. ESC Heart Failure 10:6, pages 3410-3418.
Crossref
Crossref
Iga Dziechciowska, Małgorzata Dąbrowska, Anna Mizielska, Natalia Pyra, Natalia Lisiak, Przemysław Kopczyński, Magdalena Jankowska-Wajda & Błażej Rubiś. (2023) miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy. Current Issues in Molecular Biology 45:12, pages 9500-9525.
Crossref
Crossref
Mohammad Saleh Sadeghi, Mohadeseh lotfi, Narges Soltani, Elahe Farmani, Jaime Humberto Ortiz Fernandez, Sheida Akhlaghitehrani, Safaa Hallol Mohammed, Saman Yasamineh, Hesam Ghafouri Kalajahi & Omid Gholizadeh. (2023) Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. Cancer Cell International 23:1.
Crossref
Crossref
Muneyoshi Kimura, Sagar Kothari, Wajiha Gohir, Jose F. Camargo & Shahid Husain. (2023) MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets. Clinical Microbiology Reviews.
Crossref
Crossref
Mai Thi Le, Huyen-Thu Nguyen, Xuan-Hung Nguyen, Xuan-Hai Do, Binh Thanh Mai, Ha Thi Ngoc Nguyen, Uyen Thi Trang Than & Thanh-Hong Nguyen. (2023) Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer. Heliyon 9:11, pages e22080.
Crossref
Crossref
Shangming Dai, Fengjiao Li, Shuoguo Xu, Jinda Hu & Lichen Gao. (2023) The important role of miR-1-3p in cancers. Journal of Translational Medicine 21:1.
Crossref
Crossref
Paul McVeigh, Erin McCammick, Emily Robb, Peter Brophy, Russell M. Morphew, Nikki J. Marks & Aaron G. Maule. (2023) Discovery of long non-coding RNAs in the liver fluke, Fasciola hepatica. PLOS Neglected Tropical Diseases 17:9, pages e0011663.
Crossref
Crossref
Sihui Li, Qianhui Huang, Qingqing Yang, Xiaohua Peng & Qiaofeng Wu. (2023) MicroRNAs as promising therapeutic agents: A perspective from acupuncture. Pathology - Research and Practice 248, pages 154652.
Crossref
Crossref
Shengyuan Huang, Yong Zhou, Yiru Zhang, Ningyuan Liu, Jiachen Liu, Liming Liu & Chengming Fan. (2023) Advances in MicroRNA Therapy for Heart Failure: Clinical Trials, Preclinical Studies, and Controversies. Cardiovascular Drugs and Therapy.
Crossref
Crossref
Maryam Daneshpour & Ali Ghadimi-Daresajini. (2023) Overview of miR-106a Regulatory Roles: from Cancer to Aging. Bioengineering 10:8, pages 892.
Crossref
Crossref
Jinhang Wei, Linlin Zhuo, Zhecheng Zhou, Xinze Lian, Xiangzheng Fu & Xiaojun Yao. (2023) GCFMCL: predicting miRNA-drug sensitivity using graph collaborative filtering and multi-view contrastive learning. Briefings in Bioinformatics 24:4.
Crossref
Crossref
Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Snur Rasool Abdullah, Hazha Jamal Hidayat, Goran Sedeeq Hama Faraj, Fattma Abodi Ali, Abbas Salihi, Aria Baniahmad, Soudeh Ghafouri-Fard, Milladur Rahman, Mark C. Glassy, Wojciech Branicki & Mohammad Taheri. (2023) Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges. Military Medical Research 10:1.
Crossref
Crossref
Mingyan Wu, Guangdong Li, Wenjun Wang & Hongsheng Ren. (2023) Emerging roles of microRNAs in septic cardiomyopathy. Frontiers in Pharmacology 14.
Crossref
Crossref
Fanchun Zeng, Chunrong Zhao, Rujie Wang, Lingyan Ren, Hao Qiu, Zhi Zou, Haibin Ding, Zhongyi Sun, Jianmei Li & Shiwu Dong. (2023) Antagonizing exosomal miR-18a-5p derived from prostate cancer cells ameliorates metastasis-induced osteoblastic lesions by targeting Hist1h2bc and activating Wnt/β-catenin pathway. Genes & Diseases 10:4, pages 1626-1640.
Crossref
Crossref
Roseleena Minz, Praveen Kumar Sharma, Arvind Negi & Kavindra Kumar Kesari. (2023) MicroRNAs-Based Theranostics against Anesthetic-Induced Neurotoxicity. Pharmaceutics 15:7, pages 1833.
Crossref
Crossref
Valeria Lucarini, Daniela Nardozi, Valentina Angiolini, Monica Benvenuto, Chiara Focaccetti, Raffaele Carrano, Zein Mersini Besharat, Roberto Bei & Laura Masuelli. (2023) Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion. Biomedicines 11:6, pages 1761.
Crossref
Crossref
Fatemeh Vand-Rajabpour, Meghan Savage, Rachel L. Belote & Robert L. Judson-Torres. (2023) Critical Considerations for Investigating MicroRNAs during Tumorigenesis: A Case Study in Conceptual and Contextual Nuances of miR-211-5p in Melanoma. Epigenomes 7:2, pages 9.
Crossref
Crossref
K. Hussain, A. Ishtiaq, I. Mushtaq & I. Murtaza. (2023) Profiling of Targeted miRNAs (8-nt) for the Genes Involved in Type 2 Diabetes Mellitus and Cardiac Hypertrophy. Molecular Biology 57:2, pages 338-345.
Crossref
Crossref
Adrija Sinha, Rahul Bhattacharjee, Basudha Bhattacharya, Aditya Nandi, Ramya Shekhar, Ankit Jana, Koustav Saha, Lamha Kumar, Swadheena Patro, Pritam Kumar Panda, Nagendra Kumar Kaushik, Mrutyunjay Suar & Suresh K. Verma. (2023) The paradigm of miRNA and siRNA influence in Oral-biome. Biomedicine & Pharmacotherapy 159, pages 114269.
Crossref
Crossref
Joanna Yang, Kathryn M. Luly & Jordan J. Green. (2022)
Nonviral nanoparticle gene delivery into the
CNS
for neurological disorders and brain cancer applications
. WIREs Nanomedicine and Nanobiotechnology 15:2.
Crossref
Crossref
Shijie Li, Zhixin Lei & Taolei Sun. (2022) The role of microRNAs in neurodegenerative diseases: a review. Cell Biology and Toxicology 39:1, pages 53-83.
Crossref
Crossref
Huiling Zhou, Wentao Jia, Lingeng Lu & Rui Han. (2023) MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment. Cancers 15:3, pages 824.
Crossref
Crossref
Łukasz Pulik, Paweł Łęgosz & Gabriela Motyl. (2023) Matrix metalloproteinases in rheumatoid arthritis and osteoarthritis: a state of the art review. Rheumatology 61:3, pages 191-201.
Crossref
Crossref
Jibing Chen, Fasheng Wu, Encun Hou, Jianying Zeng, Fujun Li & Hongjun Gao. (2023) Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer. Technology in Cancer Research & Treatment 22.
Crossref
Crossref
Gavin M. Traber & Ai-Ming Yu. (2023) RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies. Journal of Pharmacology and Experimental Therapeutics 384:1, pages 133-154.
Crossref
Crossref
Anetta Wronska. (2023) The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments. Journal of Pharmacology and Experimental Therapeutics 384:1, pages 123-132.
Crossref
Crossref
Ali Rastegari, Homa Faghihi & Zohreh Mohammadi. 2023. Handbook of Biomolecules. Handbook of Biomolecules
439
466
.
Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart & David Spellmeyer. 2023. Managing the Drug Discovery Process. Managing the Drug Discovery Process
339
415
.
Caroline Zhang & Biliang Zhang. (2022) RNA therapeutics: updates and future potential. Science China Life Sciences 66:1, pages 12-30.
Crossref
Crossref
Luis Alberto Bravo-Vázquez, Ixchel Medina-Ríos, Luis David Márquez-Gallardo, Josué Reyes-Muñoz, Francisco I. Serrano-Cano, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy & Sujay Paul. (2022) Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review. Digestive Diseases and Sciences 68:1, pages 38-53.
Crossref
Crossref
Kevin M. Pham & Peter A. Beal. 2023. Handbook of Chemical Biology of Nucleic Acids. Handbook of Chemical Biology of Nucleic Acids
1173
1199
.
Pallabi Sengupta, Nilanjan Banerjee, Anindya Dutta, Madhurima Chaudhuri & Subhrangsu Chatterjee. 2023. Nucleic Acid Biology and its Application in Human Diseases. Nucleic Acid Biology and its Application in Human Diseases
321
348
.
Kevin M. Pham & Peter A. Beal. 2022. Handbook of Chemical Biology of Nucleic Acids. Handbook of Chemical Biology of Nucleic Acids
1
27
.
Alexis Southwell, M. Neal Guentzel & Rishein Gupta. 2023. RNA Structure and Function. RNA Structure and Function
421
439
.
Łukasz Pulik, Bartosz Mierzejewski, Aleksandra Sibilska, Iwona Grabowska, Maria Anna Ciemerych, Paweł Łęgosz & Edyta Brzóska. (2022) The role of miRNA and lncRNA in heterotopic ossification pathogenesis. Stem Cell Research & Therapy 13:1.
Crossref
Crossref
Yohei Sekino, Jun Teishima, Gangning Liang & Nobuyuki Hinata. (2022) Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma. International Journal of Urology 29:12, pages 1419-1428.
Crossref
Crossref
Menna Siddiqui, Cristina Tous & Wilson W Wong. (2022) Small molecule-inducible gene regulatory systems in mammalian cells: progress and design principles. Current Opinion in Biotechnology 78, pages 102823.
Crossref
Crossref
Maryam Mahjoubin-Tehran, Seyed Hamid Aghaee-Bakhtiari, Amirhossein Sahebkar, Alexandra E. Butler, Reza Kazemi Oskuee & Amin Jalili. (2022) In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis. Scientific Reports 12:1.
Crossref
Crossref
Man Amanat, Christina L. Nemeth, Amena Smith Fine, Doris G. Leung & Ali Fatemi. (2022) Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology. Pharmaceutics 14:11, pages 2389.
Crossref
Crossref
Shivnarayan Dhuppar & Gopal Murugaiyan. (2022) miRNA effects on gut homeostasis: therapeutic implications for inflammatory bowel disease. Trends in Immunology 43:11, pages 917-931.
Crossref
Crossref
Juntao Li, Hongmei Zhang & Fugen Gao. (2022) Identification of miRNA biomarkers for breast cancer by combining ensemble regularized multinomial logistic regression and Cox regression. BMC Bioinformatics 23:1.
Crossref
Crossref
Atqiya Fariha, Ithmam Hami, Mahafujul Islam Quadery Tonmoy, Shahana Akter, Hasan Al Reza, Newaz Mohammed Bahadur, Md. Mizanur Rahaman & Md Shahadat Hossain. (2022) Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment. Heliyon 8:10, pages e11081.
Crossref
Crossref
Xiaolu Guan, Baocun Zhang & Li Sun. (2022) TNFR2 is a regulatory target of pol-miR-194a and promotes the antibacterial immunity of Japanese flounder Paralichthys olivaceus. Developmental & Comparative Immunology 135, pages 104477.
Crossref
Crossref
Amrutha Menon, Noraini Abd-Aziz, Kanwal Khalid, Chit Laa Poh & Rakesh Naidu. (2022) miRNA: A Promising Therapeutic Target in Cancer. International Journal of Molecular Sciences 23:19, pages 11502.
Crossref
Crossref
Mamta Panda, Elora Kalita, Satyendra Singh, Ketan Kumar, Abhishek Rao & Vijay Kumar Prajapati. (2022) MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies. Life Sciences 305, pages 120761.
Crossref
Crossref
Estelle Deboever, Alessandra Fistrovich, Christopher Hulme & Travis Dunckley. (2022) The Omnipresence of DYRK1A in Human Diseases. International Journal of Molecular Sciences 23:16, pages 9355.
Crossref
Crossref
Yue Zhao, Feng Qin, Shuang Han, Shu Li, Ying Zhao, Hongbo Wang, Jingwei Tian & Xiaobo Cen. (2022) MicroRNAs in drug addiction: Current status and future perspectives. Pharmacology & Therapeutics 236, pages 108215.
Crossref
Crossref
Charles Holjencin & Andrew Jakymiw. (2022) MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention. Cells 11:15, pages 2332.
Crossref
Crossref
Yong-Jian Guan, Chang-Qing Yu, Li-Ping Li, Zhu-Hong You, Zhong-Hao Ren, Jie Pan & Yue-Chao Li. (2022) BNEMDI: A Novel MicroRNA–Drug Interaction Prediction Model Based on Multi-Source Information With a Large-Scale Biological Network. Frontiers in Genetics 13.
Crossref
Crossref
Xin-Qi Teng, Jian Qu, Guo-Hua Li, Hai-Hui Zhuang & Qiang Qu. (2022) Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Fu-shin X. Yu, Patrick S.Y. Lee, Lingling Yang, Nan Gao, Yangyang Zhang, Alexander V. Ljubimov, Ellen Yang, Qingjun Zhou & Lixin Xie. (2022) The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas. Progress in Retinal and Eye Research 89, pages 101039.
Crossref
Crossref
Cheol-Hee Shin, Su Chan Park, Il-Geun Park, Hyerim Kim, Byoungha An, Choongil Lee, Sang-Heon Kim, Juyong Lee, Ji Min Lee & Seung Ja Oh. (2022) Cytosolic microRNA-inducible nuclear translocation of Cas9 protein for disease-specific genome modification. Nucleic Acids Research 50:10, pages 5919-5933.
Crossref
Crossref
Omid Kooshkaki, Arghavan AsghariReza MahdaviGhodsiyeh AzarkarNegin Parsamanesh. (2022) Potential of MicroRNAs As Biomarkers and Therapeutic Targets in Respiratory Viruses: A Literature Review. DNA and Cell Biology 41:6, pages 544-563.
Crossref
Crossref
Caroline Diener, Andreas Keller & Eckart Meese. (2022) Emerging concepts of miRNA therapeutics: from cells to clinic. Trends in Genetics 38:6, pages 613-626.
Crossref
Crossref
Pradeep Kota. (2022) Sustained inhibition of ENaC in CF: Potential RNA-based therapies for mutation-agnostic treatment. Current Opinion in Pharmacology 64, pages 102209.
Crossref
Crossref
RuiYan Mei, WeiWei Qin, YanHua Zheng, Zhuo Wan & Li Liu. (2022) Role of Adipose Tissue Derived Exosomes in Metabolic Disease. Frontiers in Endocrinology 13.
Crossref
Crossref
Briana Wilson & Anindya Dutta. (2022) Function and Therapeutic Implications of tRNA Derived Small RNAs. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Xiaotong Peng, Yanqun Mo, Junliang Liu, Huining Liu & Shuo Wang. (2022) Identification and Validation of miRNA-TF-mRNA Regulatory Networks in Uterine Fibroids. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Yuanyuan Jiang, Xiang Xu, Long Xiao, Lihong Wang & Sheng Qiang. (2022) The Role of microRNA in the Inflammatory Response of Wound Healing. Frontiers in Immunology 13.
Crossref
Crossref
Sheuli Kangsa Banik, Somorita Baishya, Anupam Das Talukdar & Manabendra Dutta Choudhury. (2022) Network analysis of atherosclerotic genes elucidates druggable targets. BMC Medical Genomics 15:1.
Crossref
Crossref
Phuong Xuan Tran, Jun Inoue, Hiroyuki Harada & Johji Inazawa. (2022) Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma. Molecular Therapy - Oncolytics 24, pages 897-908.
Crossref
Crossref
Ng Desi, Velda Teh, Qing Yun Tong, Chun You Lim, Hossein Tabatabaeian, Xiao Hong Chew, Avencia Sanchez-Mejias, Jia Jia Chan, Bin Zhang, Priyankaa Pitcheshwar, Bei-En Siew, Shi Wang, Kuok-Chung Lee, Choon-Seng Chong, Wai-Kit Cheong, Bettina Lieske, Ian Jse-Wei Tan, Ker-Kan Tan & Yvonne Tay. (2021) MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers. Oncogene 41:8, pages 1178-1189.
Crossref
Crossref
Jyothsna Manikkath, Padacherri Vethil Jishnu, Peter R Wich, Aparna Manikkath & Raghu Radhakrishnan. (2022) Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis. Nanomedicine 17:3, pages 181-195.
Crossref
Crossref
Zhi Xiong Chong, Swee Keong Yeap, Wan Yong Ho & Chee Mun Fang. (2022) Unveiling the tumour-regulatory roles of miR-1275 in cancer. Pathology - Research and Practice 230, pages 153745.
Crossref
Crossref
Karin Kornmueller, Ez-Zoubir Amri, Marcel Scheideler & Ruth Prassl. (2022) Delivery of miRNAs to the adipose organ for metabolic health. Advanced Drug Delivery Reviews 181, pages 114110.
Crossref
Crossref
Ajit Vikram. (2022) The Enticing Path of miR Therapeutics: Difficult but Not without Prospects. Cells 11:3, pages 418.
Crossref
Crossref
Audrius Kilikevicius, Gunter Meister & David R Corey. (2022) Reexamining assumptions about miRNA-guided gene silencing. Nucleic Acids Research 50:2, pages 617-634.
Crossref
Crossref
Gordana Supic, Debora Stefik, Nemanja Ivkovic, Ahmad Sami, Katarina Zeljic, Sasa Jovic, Ruzica Kozomara, Danilo Vojvodic & Srboljub Stosic. (2022) Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas. Scientific Reports 12:1.
Crossref
Crossref
Eun-Jeong Won, Hyeji Park, Tae-Jong Yoon & Young-Seok Cho. (2022) Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics. Pharmaceutics 14:1, pages 137.
Crossref
Crossref
Oxana V. Klimenko & Alexey Sidorov. 2022.
Brandon Bautista-Becerril, Guillermo Pérez-Dimas, Paola C. Sommerhalder-Nava, Alejandro Hanono, Julio A. Martínez-Cisneros, Bárbara Zarate-Maldonado, Evangelina Muñoz-Soria, Arnoldo Aquino-Gálvez, Manuel Castillejos-López, Armida Juárez-Cisneros, Jose S. Lopez-Gonzalez & Angel Camarena. (2021) miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19. Viruses 14:1, pages 41.
Crossref
Crossref
Evelyn C Mollocana-Lara, Ming Ni, Spiros N Agathos & Fernando A Gonzales-Zubiate. (2021) The infinite possibilities of RNA therapeutics. Journal of Industrial Microbiology and Biotechnology 48:9-10.
Crossref
Crossref
Isra Saif Eldin Eisa Sati & Ishwar Parhar. (2021) MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma. International Journal of Molecular Sciences 22:24, pages 13550.
Crossref
Crossref
Keiko Mizuno, Kengo Tanigawa, Shunsuke Misono, Takayuki Suetsugu, Hiroki Sanada, Akifumi Uchida, Minami Kawano, Kentaro Machida, Shunichi Asai, Shogo Moriya, Hiromasa Inoue & Naohiko Seki. (2021) Regulation of Oncogenic Targets by Tumor-Suppressive miR-150-3p in Lung Squamous Cell Carcinoma. Biomedicines 9:12, pages 1883.
Crossref
Crossref
Rossana Cuciniello, Stefania Filosa & Stefania Crispi. (2021) Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Wioleta Grabowska-Pyrzewicz, Andrew Want, Jerzy Leszek & Urszula Wojda. (2021) Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm. eBioMedicine 74, pages 103691.
Crossref
Crossref
Hartwig Visser & Adam D. Thomas. (2021) MicroRNAs and the DNA damage response: How is cell fate determined?. DNA Repair 108, pages 103245.
Crossref
Crossref
Reema R. Barik & Lokesh Kumar Bhatt. (2021) Emerging epigenetic targets in rheumatoid arthritis. Rheumatology International 41:12, pages 2047-2067.
Crossref
Crossref
Bayley Matthews, Nikola Bowden & Michelle Wong-Brown. (2021) Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer. Cancers 13:23, pages 5993.
Crossref
Crossref
Ishita Gupta, Semir Vranic, Hamda Al-Thawadi & Ala-Eddin Al Moustafa. (2021) Fascin in Gynecological Cancers: An Update of the Literature. Cancers 13:22, pages 5760.
Crossref
Crossref
Mohammad Yahya Momin, Ravinder Reddy Gaddam, Madeline Kravitz, Anisha Gupta & Ajit Vikram. (2021) The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint. Cells 10:11, pages 3097.
Crossref
Crossref
Hannah Walgrave, Lujia Zhou, Bart De Strooper & Evgenia Salta. (2021) The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives. Molecular Neurodegeneration 16:1.
Crossref
Crossref
Dimitri Papukashvili, Nino Rcheulishvili, Cong Liu, Fengfei Xie, Deependra Tyagi, Yunjiao He & Peng George Wang. (2021) Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy. Cells 10:11, pages 2957.
Crossref
Crossref
Po-Shuan Huang, Chia-Jung Liao, Ya-Hui Huang, Chau-Ting Yeh, Cheng-Yi Chen, Hui-Chi Tang, Cheng-Chih Chang & Kwang-Huei Lin. (2021) Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer. Cancers 13:21, pages 5361.
Crossref
Crossref
Michał Czerwiński, Anna Bednarska-Czerwińska, Paweł Ordon, Magdalena Gradzik, Marcin Oplawski, Dariusz Boroń, Hanna Zientek, Oskar Ogloszka & Beniamin Oskar Grabarek. (2021) Variances in the Expression of mRNAs and miRNAs Related to the Histaminergic System in Endometrioid Endometrial Cancer. Biomedicines 9:11, pages 1535.
Crossref
Crossref
Nouf M. Alyami. (2021) MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia. Frontiers in Oncology 11.
Crossref
Crossref
Mingyao Luo, Mingyuan Du, Chang Shu, Sheng Liu, Jiehua Li, Lei Zhang & Xin Li. (2021) The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook. Frontiers in Pharmacology 12.
Crossref
Crossref
Min Ju Kim, Hyeyoun Chang, Gihoon Nam, Youngji Ko, Sun Hwa Kim, Thomas M. Roberts & Ju Hee Ryu. (2021) RNAi-Based Approaches for Pancreatic Cancer Therapy. Pharmaceutics 13:10, pages 1638.
Crossref
Crossref
Song Zhang & Feng Zhu. (2021) Comment on: “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”. Drugs 81:14, pages 1691-1692.
Crossref
Crossref
Hisham Kashif, Dilan Shah & Sangeetha Sukumari-Ramesh. (2021) Dysregulation of microRNA and Intracerebral Hemorrhage: Roles in Neuroinflammation. International Journal of Molecular Sciences 22:15, pages 8115.
Crossref
Crossref
Hsiuying Wang. (2021) MicroRNAs, Multiple Sclerosis, and Depression. International Journal of Molecular Sciences 22:15, pages 7802.
Crossref
Crossref
Soha Reda El Sayed, Justine Cristante, Laurent Guyon, Josiane Denis, Olivier Chabre & Nadia Cherradi. (2021) MicroRNA Therapeutics in Cancer: Current Advances and Challenges. Cancers 13:11, pages 2680.
Crossref
Crossref
Hironori Adachi, Martin Hengesbach, Yi-Tao Yu & Pedro Morais. (2021) From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies. Biomedicines 9:5, pages 550.
Crossref
Crossref
Anna Maria Grimaldi, Marco Salvatore & Mariarosaria Incoronato. (2021) miRNA-Based Therapeutics in Breast Cancer: A Systematic Review. Frontiers in Oncology 11.
Crossref
Crossref